Yushin Company (6482) Q1 2025 earnings summary

Executive summary

• Net sales rose 19.7% year-over-year to ¥5,589 million for the quarter ended June 30, 2024, driven by strong custom-ordered equipment sales, especially in Europe.

• Operating profit declined 14.4% year-over-year to ¥123 million due to higher personnel expenses despite improved gross margin.

• Profit attributable to owners of parent fell 19.5% year-over-year to ¥104 million.

• Sales in the Americas and Asia decreased, while Europe saw significant growth due to subsidiary consolidation and large medical equipment orders.

Financial highlights

• Gross profit increased to ¥2,168 million from ¥1,798 million year-over-year.

• Ordinary profit dropped 36.4% year-over-year to ¥163 million.

• Comprehensive income rose 3.2% year-over-year to ¥714 million.

• Basic earnings per share was ¥3.06, down from ¥3.80 in the prior year.

Outlook and guidance

• Full-year consolidated earnings forecasts remain unchanged: net sales of ¥25,500 million (+8.0% YoY), operating profit of ¥2,600 million (+6.7% YoY), and profit attributable to owners of parent of ¥1,800 million (+6.4% YoY).

• Annual dividend forecast is ¥20 per share.